Tatiana Mareeva

Title: Tatiana Mareeva: Innovator in Monoclonal Antibodies

Introduction

Tatiana Mareeva is a prominent inventor based in Haddonfield, NJ (US). She has made significant contributions to the field of monoclonal antibodies, with a focus on their production and application in various assays. With a total of 4 patents to her name, her work is paving the way for advancements in medical diagnostics.

Latest Patents

Tatiana's latest patents include groundbreaking innovations such as anti-naloxone and anti-naltrexone monoclonal antibodies. These antibodies specifically bind to naloxone or naltrexone, providing methods for their production and use. Additionally, her work includes methods for reducing interference in opiate assays using these antibodies. Another notable patent involves binding partners specific for vitamin D epimers, which are designed to minimize cross-reactivity in assays for non-epimeric forms of vitamin D analytes.

Career Highlights

Tatiana Mareeva is currently employed at Siemens Healthcare Diagnostics GmbH, where she continues to develop her innovative ideas. Her expertise in monoclonal antibodies has positioned her as a key player in the field of diagnostics.

Collaborations

Tatiana collaborates with talented coworkers such as Zhu Teng and Manoj Sharma, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tatiana Mareeva's contributions to the field of monoclonal antibodies are significant and impactful. Her patents reflect her dedication to advancing medical diagnostics and improving patient care.